1 year ago
CAR-T Cells B Cell Lymphoma Elderly Patients Can Also Benefit Diffuse large B-cell lymphoma (DLBCL) is the most common type of aggressive lymphoma, with a median age at diagnosis of 66 years, and a...
1 year ago
2024 ASCO China Voice: China’s TIL therapy makes a grand debut, targeting ovarian cancer. **GC203: A Powerful Strike Against Ovarian Cancer with an 83.3% Disease Control Rate** TIL therapy Ov...
1 year ago
[2024 EHA] Excellent Efficacy of CAR-T Cell Yescarta in Patients with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma: A Study from the French Registry The 2024 European Hematology...
1 year ago
### The Hidden “Anti-Cancer Weapon” in Tumor Tissue – TIL Cells TIL Therapy **TIL Cells: Turning Tumor Tissue “Waste” into Treasure** Lymphocytes are a crucial par...
1 year ago
CAR-T Cell Treatment for Lymphoma, Igniting New Hope for Patients’ Survival June 22nd, CAR-T Day: CAR-T Ignites New Hope for Patients with Relapsed/Refractory Lymphoma June 22nd is designated...
1 year ago
Application of CAR-T Cell Non Hodgkin Lymphoma Therapy In the past, cancer was primarily treated through surgery, chemotherapy, and radiotherapy. In recent years, cancer immunotherapy, which stimul...
1 year ago
Can Patients Recover Normal Life after CAR-T Cell Lymphoma Treatment: Examining the Research Findings Chimeric antigen receptor T cells (CAR-T cells) can induce long-term remissions in many patient...
1 year ago
CAR-T Cell Kymriah (Tisagenlecleucel) Demonstrates Durable Responses and Favorable Safety in Patients with Relapsed/Refractory Follicular Lymphoma Follicular lymphoma (FL), an indolent form of non-...
1 year ago
New Hope of CAR-T Cell Hodgkin’s Lymphoma Treatment CAR-T cell therapy has emerged as a promising treatment for hematologic malignancies, but the targets approved by the US FDA for CAR-T cell...
1 year ago
**Thérapie révolutionnaire apporte un nouvel espoir : le patient suisse Thomas commence le traitement CAR-T à l’hôpital Tongji de Wuhan** L’équipe du professeur Li Chunrui de l’h...
1 year ago
**Breakthrough Therapy Brings New Hope: Swiss Patient Thomas Begins CAR-T Treatment at Tongji Hospital, Wuhan** Professor Li Chunrui’s team at Tongji Hospital in Wuhan successfully conducted...
1 year ago
New Hope for Patients with CAR-T Cell Follicular Lymphoma Follicular lymphoma is a lymphoproliferative disorder originating from B cells. It is a type of non-Hodgkin’s lymphoma, and the B-cel...
By using our site, you agree to our Terms and Conditions and Privacy Policy.Advanced Medicine In China does not provide medical advice, diagnosis, or treatment. The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician.
© Copyright 2023 Advanced Medicine In China. All rights reserved.
